9th Postgraduate Course in Infectious and Tropical Diseases By: FRANCESCA CANDO-GAJETE,MD,MHA Manager- National Leprosy Control Program National Center for Disease Prevention and Control Department of Health
Jan 19, 2016
9th Postgraduate Course in Infectious and Tropical Diseases
By: FRANCESCA CANDO-GAJETE,MD,MHA
Manager- National Leprosy Control Program
National Center for Disease Prevention and Control
Department of Health
Improve case
detection and
Surveillance
System in low
endemicity
settings
Advocacy for
Leprosy and
Human
Dignity with
Leprosy
Recoverers
Ensure the
availability
of
adequate
anti-leprosy
drugs
NLCP Ongoing and Planned projects for 2013
Mission : the provision of a comprehesive, integrated quality leprosy services at all levels of health care with the active participation of persons affected by leprosy & other stakeholders
Integration of
Leprosy
control and
other
services at
local level
Strengthen
the
collaboration
of partners
and other
stakeholders
61 2 3 4 5
RESEARCH – BOD, Retrospective study of leprosy cases, national rapid tests among HHC
Best Practices and Innovative Ideas Contest
Changed landscape in leprosy prevalence and developments in public health approaches lead ask for cost-effective and strategic activities
E-learning
Mobile health
Contact tracing
School-based programs
Data management
RPOID SAPEL
Participation of Leprosy Recoverers
Consultation, engagement and collaborational arrangements (MOA, MOU) with public and private partners
Prevention
and
reduction of
disabilities
from
leprosy
For 2013-2018, we aim to:
•Decrease by 50% the identified hyperendemicmunicipalities by 2018;•Establish referral units in all regions;•Establish the Standardized E-Reporting system for NLCP;•Develop the Counselling Modules for Frontline Healthworkers; •Develop the hub for the Community of Practice;•Develop Leprosy Research Agenda with RITM & Leonard Wood; and
•Identify and declare “Leprosy-free municipalities”
NLCP TARGET
Leprosy Elimination in the Philippines
1982 1986 1998 2000 2002 20072005 2010
MDTPiloted
Global appeal
•1st National Leprosy Summit•MOA w/ PDS
•National Skin Disease Awareness Week•A.O. 2005-2013- 8 Sanitaria conversion
Dr. Jose N.Rodriguez
Award
DecentralizationEliminated
as publichealth
problemPR 0.9/10,000
NLCP EstablishedPR 7.2/ 10,000(32,570 cases)
PR 0.31/10,000
Leprosy Elimination in WPR
1985
MDT initiated
1991 1994 1999
Post elimination surveillance
system (PESS)
guidelines developed
Regional elimination
achieved
2000
Elimination in 35 /37 countries
2004 2009
Bi-Regional meeting with
SEARO on Post-
Elimination Strategies
100% MDT coverage
2010
WPR Framework for
Leprosy
for PICs
Elimination in 34/37 countries
Trends in the Detection of New Cases of Leprosy(2004 – 2011)
No. of new cases detected
WHO Region 20112010200920082007200620052004
12 67325 34528 93529 81434 46834 48045 17946 918African
36 83237 74040 47441 89142 13547 61241 95252 662Americas
160 132156 254166 115167 505171 576
174 118
201 635298 603South East Asia
4 3464 0804 0293 9384 0913 2613 1333 392Eastern Mediterranean
5 0925 0555 2435 8595 8636 1907 1376 216Western Pacific
219 075228 474244 796249 007258 133
265 661
299 036407 791TOTAL
Registered Prevalence of Leprosy & # of New Cases Detected in 105 Countries or Territories (2011 & 1st Q of 2012)
No. of new cases detected and case-
detection rate, 2011
No. of cases registered and the prevalence, 1st
Q 2012
WHO Region
12 673 (3.14)15 006 (0.37)African
36 832 (4.18)34 801 (0.40)Americas
160 132 (8.75)117 147 (0.64)South East Asia
4 346 (0.71)7 368 (0.12)Eastern Mediterranean
5 092 (0.30)7 619 (0.05)Western Pacific
219 075 (4.06)181 941 (0.34)TOTAL
Number of cases of leprosy (rate/100 000 population) w/ Grade 2 disabilities detected among new cases (2005 – 2011)
Year
WHO Region
2011201020092008200720062005
1 446 (0.36)
2 685 (0.40)
3 146 (0.41)
3 458 (0.51)
3 570 (0.51)
3 244 (0.46)
4 562 (0.62)
African
2 382 (0.27)
2 423 (0.27)
2 645 (0.30)
2 512 (0.29)
3 431 (0.42)
2 302 (0.27)
2 107 (0.25)
Americas
753
(0.12)
729
(0.12)
608
(0.11)
687
(0.14)
466
(0.10)
384
(0.08)
335
(0.07)
Eastern Mediterranean
7 095
(0.39)
6 912
(0.39)
7 286
(0.41)
6 891
(0.39)
6 332
(0.37)
5 791
(0.35)
6 209
(0.37)
South East Asia
549
(0.03)
526
(0.03)
635
(0.04)
592
(0.03)
604
(0.03)
671
(0.04)
673
(0.04)
Western Pacific
12 225 (0.23)
13 275 (0.23)
14 320 (0.25)
14 140 (0.25)
14 403 (0.26)
12 392 (0.23)
13 886 (0.25)
TOTAL
0% 5% 10% 15% 20% 25% 30% 35%
Other countries
Lao People's Democratic Republic
Kiribati
Marshall Islands
Micronesia (Federated States of)
Malaysia
Papua New Guinea
Cambodia
Viet Nam
China
Philippines
Distribution of new leprosy cases, 2011
• 2006- Mr. Yohei Sasakawa, Chairman of The Nippon Foundation led an annual Global Appeal to End Stigma and Discrimination against People Affected by Leprosy
• This appeal has been an attempt, both to raise public awareness through the media, and to draw in the support of world leaders, representatives of people affected by leprosy, and organizations concerned with human rights in general
• On discrimination: "We don't get complaints, because people affected by leprosy don't realize these are human rights issues as well"
-Cecilia Quisumbing, Commission on Human Rights
• We must raise awareness of UN-adopted Principles and Guidelines to end discrimination against people affected by leprosy and their families
Global Appeal 2007Held in the Philippines and spearheaded
by the National Leprosy Control Program,
the 2007 Global Appeal was signed by 16
people affected by leprosy from 13
countries together with the WHO
Goodwill Ambassador Yohei Sasakawa.
Their message: “Silence on the issue is
not acceptable. We urge you to join us in
the fight to end social injustice”.
The Evolution of the Global Appeal• 2008- emphasized that diagnosed and treated promptly,
leprosy leaves no trace. Far harder to remove is the age-old stigma.
• 2009- called for people to stop using the word “leper”
• 2010- urges all physicians, health professionals and civil society to engage themselves in combating all forms of prejudice and discrimination.
- Further, research centres should acknowledge leprosy as a major public health problem and continue to research into it.
The Evolution of the Global Appeal• 2011- all National Medical Associations defend the
right of people affected by leprosy and their family members to be treated with dignity and free from any kind of prejudice or discrimination.
• 2012- Leprosy is curable, treatment is free and there must be no more social stigma in the twenty-first century.
-“A patient is not really cured until stigma ends”
Why participate?
• There are many myths and misconceptions about leprosy. As members of the medical
profession, we have the first responsibility to set the record straight
THE FACTS
• Leprosy is a mildly infectious disease.
• It is not spread by casual contact.
• It is curable with antibiotics that kill the bacteria and stop the disease from spreading.
THE FACTS
• Early diagnosis and prompt treatment help prevent the onset of disability and deformity associated with leprosy.
• There are no medical grounds for isolating a person with the disease
• Treatment is FREE
“Start focusing on being everything to someone. Helping or pleasing everyone is impossible. But making one person smile can
change the world. Maybe not the whole world, but their world”